<DOC>
	<DOCNO>NCT02092194</DOCNO>
	<brief_summary>Online hemodiafiltration ( HDF ) may improve clinical outcome end-stage renal disease . The supported mechanism improve clearance uremic toxin convective transporter . However , It elucidate convection volume optimal , especially Asia . A total 60 participant receive conventional hemodialysis randomly assign receive either high dose convective volume ( 33-43 L/treatment ) post-dilution online HDF standard dose ( 16.8-21.5 L/treatment ) 24 week . The primary outcome change serum β2 microglobulin level baseline 24 week . The secondary outcome include change nutritional marker , inflammatory marker , blood pressure baseline treatment . This would first multicenter prospective , randomize control trial determine whether large convective volume improve treatment efficacy Korean patient undergo post-dilution online HDF .</brief_summary>
	<brief_title>High Versus Standard Volume Hemodiafiltration Asia</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients thriceweekly standard hemodialysis &gt; 3 month Patients vascular access capable deliver consistently high blood flow rate ( ≥ 300 mL/min ) Patients willing provide write informed consent . Patients active infectious uncontrolled inflammatory disorder Patients uncontrolled malignant disease Patients recent major cardiovascular disease last 6 month Patients likely receive kidney transplant within follow 1 year Patients whose life expectancy &lt; 12 month Patients consider investigator difficulty participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>beta 2-Microglobulin</keyword>
	<keyword>Hemodiafiltration</keyword>
	<keyword>convective volume</keyword>
</DOC>